Metabolites such as butyrate, short-chain fatty acids, and acetate have been reported to improve gut barrier function (Peng et al., 2009), suppress the accumulation of insulin-mediated fat in adipose tissue (Kimura et al., 2013), and also contribute to prevention of colonic diseases in the host. Here, INS is linked to colonic disorder.